Security key
22978P106
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 18,058,960
- Total 13F value
- $12,982,249
- Share change
- +723,240
- SEC-reported price per share
- $0.72
- Number of holders
- 52
- Value change
- +$519,709
- Number of buys
- 14
- Number of sells
- 16
- Shares outstanding
- 43,411,663
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
52
Top holders
10
CUE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Cue Biopharma, Inc. SEC filings
Cue Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22978P106
Recent filing periods:
Ownership snapshot
Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bleichroeder LP
Disclosed value leader
Bleichroeder LP
Comparable rows
3/15
Latest evidence
30 Jun 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
12 rows are not safely comparable across share classes.
13D/G row: Bleichroeder LP
Showing 1-6 of 15 holder rows.
Quick read
Bleichroeder LP leads the comparable SEC ownership view at 10%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bleichroeder LP's linked filing trail.
Comparable ownership
Top 3
Bleichroeder LP
10%
Mark E. Strome
5%
Slate Path Capital LP
1.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bleichroeder LP |
13D/G
13F
Company
|
10%
Reported 13D/G
· 19 Mar 2025
|
$5,269,789
6,127,662 shares
|
$0 | 19 Mar 2025 |
| Mark E. Strome |
13D/G
|
5%
Reported 13D/G
· 14 Nov 2022
|
$1,862,968
2,166,242 shares
|
$0 | 14 Nov 2022 |
| Slate Path Capital LP |
13D/G
|
1.4%
Reported 13D/G
· 31 Dec 2024
|
$790,199
918,836 shares
|
$0 | 31 Dec 2024 |
| Michael J. Fox |
3/4/5
Director
|
—
mixed-class rows
|
$3,036,000
1,148,800 shares
mixed-class rows
|
— | 05 Jun 2024 |
| GC Wealth Management RIA, LLC |
13F
Company
|
—
denominator unverified
|
$2,273,181
3,331,644 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$2,173,770
3,187,346 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
52
Shares
18,058,960
Rows available
52
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q4 2025 Across Filers
Q4 2025 holders
48
Q3 2025 holders
52
Holder diff
4
| Investor | Q4 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend